CFDB - Cystic Fibrosis DataBase

ongoing trials trial from

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis - Phase 2|Phase 3 - Not yet recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment


Cystic Fibrosis|Abdominal Pain|Small Bowel Disease - 12 Years and older   (Child, Adult, Older Adult)


Drug: Rifaximin 550 MG Oral Tablet [XIFAXAN]|Drug: Placebo

Outcome measures

Rifaximin Treatment Group Improvement of Symptoms|Improved ePROS scores

Keywords: Rifaximin; other anti-bacterial agents; Anti-Bacterial Agents; pharmacological_intervention;